Skip to content
ProcedureFinder
Last updated May 17, 2026
Our editorial process →
Home / Injectables / Daxxify (daxibotulinumtoxinA)
Injectables FDA-Approved

Daxxify (daxibotulinumtoxinA) Cost (2026)

Daxxify (daxibotulinumtoxinA) costs $480 - $850 nationally in 2026, with a median of $600. Pricing varies significantly by metro market, provider credentials, and case complexity.

Low end
$480
National Median
$600
High end
$850
Cost unit: per glabellar treatment (20 units)

Get matched with Daxxify (daxibotulinumtoxinA) clinics near you

Free, no obligation. We send your request to 2-4 verified clinics for quotes and financing options.

By submitting you agree to be contacted by clinics matched to your request. We do not sell your information to third parties.

About Daxxify (daxibotulinumtoxinA)

Daxxify (daxibotulinumtoxinA from Revance Aesthetics) is the newest FDA-approved botulinum toxin in the US market (approved 2022). The product uses a peptide excipient instead of human serum albumin, and clinical trials demonstrated 6-month median duration vs the 3-4 months typical for Botox, Dysport, and Xeomin. Adoption growing in 2026 driven by patients wanting fewer injections per year. Average $16-$22 per unit ($480-$660 per glabellar treatment).

What it is

Injectable daxibotulinumtoxinA at 20 units glabellar dose (1:1 with Botox dosing for cosmetic use). Mechanism identical to other botulinum toxins: blocks neuromuscular signaling at the injection site. Unique peptide-stabilized formulation produces longer duration.

Who it is for

Adults seeking neuromodulator treatment for dynamic facial wrinkles (glabellar, forehead, crows feet) who want fewer treatments per year. Premium-priced; appropriate when 2x/year treatment cadence is preferred over 3-4x/year with other neuromodulators.

What is typically included

  • Consultation
  • 20 unit glabellar treatment
  • Post-treatment care

Procedure snapshot

Category
Injectables
Timeline
1 day
Typical recovery
0 days
Financing common
No
Evidence level
FDA-Approved

Cost factors

Units used

+$80 to +$1,500

Glabellar: 20 units. Forehead: 10-20 units. Crows feet: 24 units (12 each side). Full face: 40-60 units total.

Provider type

+$0 to +$300

Dermatology or plastic surgery practices charge premium over medical spas.

Daxxify rewards program

-$100 to -$25

Revance has a loyalty program offering discounts on repeat treatments.

Daxxify (daxibotulinumtoxinA) Cost by City

Median daxxify (daxibotulinumtoxina) pricing across top US metros.

Frequently asked questions

How much does Daxxify cost in 2026? +

Per unit: $16-$22 in US. Glabellar treatment (20 units): $480-$660. Full face (forehead + glabellar + crows feet, 40-60 units): $720-$1,200. Daxxify is premium-priced vs Botox ($14-$20/unit) reflecting the longer duration.

Does Daxxify really last 6 months? +

Clinical trials showed median duration of 6 months at the glabellar site (vs 3-4 months for other neuromodulators). Individual patient duration varies: some patients see 6+ months, others see closer to 4-5 months. Real-world median in 2026 is approximately 4-5 months at glabellar, slightly shorter at other facial sites.

Daxxify vs Botox? +

Daxxify: 6-month median duration in trials, $16-$22/unit, peptide excipient. Botox: 3-4 month duration, $14-$20/unit, human serum albumin excipient. For patients wanting fewer treatments per year and budget tolerates premium, Daxxify is the practical choice. For cost-conscious patients comfortable with 3-4x annual treatments, Botox remains the value option.

Is Daxxify safer than Botox? +

Safety profiles are comparable. Both are FDA-approved with established clinical use. Daxxify is newer with less long-term human use data; Botox has 23+ years of cosmetic use. Common side effects (bruising, headache, eyelid heaviness) similar across all neuromodulators.

Will Daxxify work for migraines like Botox? +

Daxxify is FDA-approved for cosmetic glabellar lines only. Botox is FDA-approved for chronic migraine. Off-label Daxxify use for migraines exists but most migraine prescribers stick with Botox where insurance coverage is established.

Sources

  1. FDA Daxxify Prescribing Information, current 2026 label. (Indication and dosing)
  2. Carruthers J et al. SAKURA Trials of Daxibotulinumtoxin A. JAMA Dermatol, 2024. (Duration evidence)